AMERICA GREAT HEALTH (AAGH) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 21, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AAGH SEC filings page.
AMERICA GREAT HEALTH (AAGH) reported $392K in revenue for fiscal year 2025, up 32.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025 sales and gross profit improved sharply, yet heavy liabilities and interest kept the business dependent on financing.
Revenue grew32.9% while gross profit rose99.8% , indicating FY2025 improvement came from a margin shift rather than sales volume alone. Gross margin expansion of29.0 percentage points and lower SG&A were offset by interest expense reaching$902K , preserving losses despite better operations.
FY2025 liabilities were
Operating cash flow improved from
Financial Health Signals
AMERICA GREAT HEALTH does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
AMERICA GREAT HEALTH scores -66.72, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $10.8M against total assets of $302K. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
AMERICA GREAT HEALTH passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
AMERICA GREAT HEALTH reported a net loss of $719K while operations used $333K of cash. With neither figure positive, the ratio between the two carries no quality signal.
AMERICA GREAT HEALTH reported an operating loss of $383K against $902K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
AMERICA GREAT HEALTH generated $26K in revenue in Q3 2026. This represents a decrease of 53.4% from the same quarter a year earlier. Against the prior quarter it is down 42.0%.
AMERICA GREAT HEALTH's EBITDA was -$73K in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
AMERICA GREAT HEALTH reported a net loss of $166K in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
AMERICA GREAT HEALTH earned $0.00 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
AMERICA GREAT HEALTH held $29K in cash against $2.4M in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
AMERICA GREAT HEALTH's gross margin was 86.2% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 2.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.2 percentage points.
Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for Q3 2026.
Capital Allocation
None of these metrics is reported for Q3 2026.
AAGH Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $26K-53.4% | $45K-50.4% | $188K+33.9% | $105K+9.3% | $56K-40.3% | $91K-0.3% | $140K+914.8% | $96K+28.1% |
| Cost of Revenue | $4K-43.0% | $9K+9.2% | $75K+560.6% | $27K-74.0% | $6K-46.9% | $8K-8.0% | $11K+6304.0% | $104K+325828.1% |
| Gross Profit | $23K-54.8% | $37K-56.0% | $113K-12.5% | $77Kn/m | $50K-39.3% | $83K+0.5% | $129K+844.8% | -$9K-111.6% |
| SG&A Expenses | $96K-28.7% | $235K+15.6% | $116K-41.9% | $184K-55.3% | $135K-37.5% | $204K-13.9% | $200K+125.4% | $411K+77.0% |
| Operating Income | -$74Kn/m | -$199Kn/m | -$3Kn/m | -$106Kn/m | -$85Kn/m | -$121Kn/m | -$71Kn/m | -$420Kn/m |
| EBITDA | -$73Kn/m | -$195Kn/m | $314n/m | -$103Kn/m | -$82Kn/m | -$117Kn/m | -$67Kn/m | -$416Kn/m |
| Interest Expense | $84K+14.8% | $84K+14.1% | $968K+34.6% | $36K+207.7% | $73K-22.5% | $73K-23.3% | $720K+56.7% | $12Kn/m |
| Income Tax | N/A | N/A | $0n/m | N/A | $0n/m | $0n/m | $0n/m | N/A |
| Net Income | -$166Kn/m | N/A | -$85Kn/m | -$222Kn/m | -$158Kn/m | -$193Kn/m | -$145Kn/m | -$589Kn/m |
| EPS (Basic) | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m |
| EPS (Diluted) | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m |
| Diluted Shares (Avg) | 21.15B0.0% | 21.15B+0.1% | N/A | N/A | 21.15B | 21.14B | N/A | N/A |
Not reported in any period shown, so not listed: R&D Expenses.
AAGH Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $167K-37.4% | $193K-31.4% | $241K-21.1% | $302K-6.7% | $267K-19.9% | $282K-13.0% | $306K+10.4% | $323K+8.1% |
| Current Assets | $146K-25.6% | $146K-27.7% | $185K-14.6% | $237K+5.0% | $196K-26.3% | $202K-18.1% | $217K+20.5% | $225K+25.6% |
| Cash & Equivalents | $29K-20.4% | $23K-36.4% | $28K-42.7% | $44K-19.8% | $37K-28.7% | $36K-50.1% | $49K-10.2% | $55K+1.5% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Inventory | $98K-9.1% | $104K-11.3% | $138K+15.7% | $165K+98.0% | $107K-19.4% | $117K-12.4% | $119K+10.1% | $83K-23.3% |
| Accounts Receivable | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% | $37K-47.1% | $37K+57.7% | $37Kn/m | $55Kn/m |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Liabilities | $5.0M-15.8% | $4.8M-16.4% | $6.0M+6.7% | $6.0M+9.4% | $5.9M+13.2% | $5.8M+13.2% | $5.6M+15.0% | $5.4M+16.7% |
| Current Liabilities | $2.6M-29.2% | $2.6M-31.0% | $3.8M+5.1% | $3.8M+6.3% | $3.7M+14.0% | $3.7M+14.8% | $3.6M+14.1% | $3.6M+21.5% |
| Non-Current Liabilities | $2.3M+7.1% | $2.3M+9.5% | $2.2M+9.4% | $2.2M+19.9% | $2.2M+11.9% | $2.1M+10.5% | $2.0M+16.6% | $1.9M+8.4% |
| Long-Term Debt | $2.4M+17.6% | $2.4M+20.8% | $2.3M+21.1% | $2.2M+21.3% | $2.1M+83.4% | $2.0M+73.8% | $1.9M+68.5% | $1.8M+20.3% |
| Total Equity | -$4.8Mn/m | -$4.6Mn/m | -$5.7Mn/m | -$5.7Mn/m | -$5.6Mn/m | -$5.5Mn/m | -$5.3Mn/m | -$5.0Mn/m |
| Retained Earnings | -$9.9Mn/m | -$9.8Mn/m | -$10.9Mn/m | -$10.8Mn/m | -$10.7Mn/m | -$10.6Mn/m | -$10.4Mn/m | -$10.1Mn/m |
Not reported in any period shown, so not listed: Goodwill.
AAGH Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2Kn/m | -$126K-242.5% | $44Kn/m | -$273Kn/m | -$53Kn/m | $89Kn/m | -$96Kn/m | -$165K-688.4% |
| Depreciation & Amortization | $979-73.5% | $4K0.0% | $4K0.0% | $4K0.0% | $4K0.0% | $4K0.0% | $4K0.0% | $4K0.0% |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0n/m |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$165K-688.4% |
| Investing Cash Flow | N/A | N/A | N/A | $0n/m | N/A | N/A | N/A | $0n/m |
| Financing Cash Flow | -$7K-112.9% | $120Kn/m | -$61K-168.5% | $278K+63.7% | $54K-44.5% | -$99K-132.5% | $88K+98.9% | $170Kn/m |
Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.
AAGH Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.2%-2.5pp | 81.0%-10.4pp | 60.1%-31.8pp | 74.1%+83.1pp | 88.7%+1.4pp | 91.4%+0.7pp | 91.9%-6.8pp | -9.0%-109.0pp |
| Operating Margin | -282.2% | -440.7% | -1.8%+48.8pp | -101.6% | -152.0% | -132.5% | -50.6% | -438.7% |
| Net Margin | -635.0% | N/A | -45.5% | -212.6% | -282.1% | -212.4% | -103.8% | -616.1% |
| Return on Assets | -99.4%-40.0pp | N/A | -35.4%+12.2pp | -73.6%+108.6pp | -59.3%+8.6pp | -68.6%+8.2pp | -47.6%+8.9pp | -182.2%-104.8pp |
| Current Ratio | 0.060.0x | 0.060.0x | 0.050.0x | 0.060.0x | 0.050.0x | 0.050.0x | 0.060.0x | 0.060.0x |
| Asset Turnover | 0.16-0.1x | 0.23-0.1x | 0.78+0.3x | 0.35+0.1x | 0.21-0.1x | 0.320.0x | 0.46+0.4x | 0.300.0x |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -173.0% |
Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, Liabilities-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Note: Shareholder equity is negative (-$5.7M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.06), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| AMERICA GREAT HEALTH AAGH | FY2025 | $392K | -$719K | N/A | $4.2M | — |
| REVIVA PHARMA HLDGS INC RVPH | FY2025 | N/A | -$19.9M | N/A | $4.6M | — |
| OSR HEALTH INC OSRH | FY2025 | $2.9M | -$18.0M | N/A | $5.3M | — |
| ADAPTIMMUNE THERAPTCS ADAPY | FY2024 | $178.0M | -$70.8M | -39.8% | $6.1M | — |
Where AMERICA GREAT HEALTH Ranks
Frequently Asked Questions
AMERICA GREAT HEALTH (AAGH) reported $392K in total revenue for fiscal year 2025. This represents a 32.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
AMERICA GREAT HEALTH (AAGH) revenue grew by 32.9% year-over-year, from $295K to $392K in fiscal year 2025.
No, AMERICA GREAT HEALTH (AAGH) reported a net loss of $719K in fiscal year 2025.
AMERICA GREAT HEALTH (AAGH) had EBITDA of -$368K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, AMERICA GREAT HEALTH (AAGH) had $44K in cash and equivalents against $2.2M in long-term debt.
AMERICA GREAT HEALTH (AAGH) had a gross margin of 86.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
AMERICA GREAT HEALTH (AAGH) had an operating margin of -97.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
AMERICA GREAT HEALTH (AAGH) recorded an outflow of $333K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
AMERICA GREAT HEALTH (AAGH) had $302K in total assets as of fiscal year 2025, including both current and long-term assets.
AMERICA GREAT HEALTH (AAGH) had a current ratio of 0.06 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
AMERICA GREAT HEALTH (AAGH) had a return on assets of -238.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
AMERICA GREAT HEALTH (AAGH) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $4.2M as of Oct 21, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
AMERICA GREAT HEALTH (AAGH) trades at 11.6x sales, its market capitalization divided by $363K revenue, trailing 12 months to March 31, 2026. The market capitalization is $4.2M as of Oct 21, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
At the end of fiscal year 2025, AMERICA GREAT HEALTH (AAGH) held $44K in cash, cash equivalents and investments, and reported an operating cash outflow of $333K over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
AMERICA GREAT HEALTH (AAGH) has negative shareholder equity of -$5.7M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
AMERICA GREAT HEALTH (AAGH) has an Altman Z-Score of -66.72, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
AMERICA GREAT HEALTH (AAGH) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
AMERICA GREAT HEALTH (AAGH) reported a net loss of $719K while operations used $333K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
AMERICA GREAT HEALTH (AAGH) reported an operating loss of $383K against $902K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.